A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Clinical trial NCT07066657 · RECRUITING

Trial details

NCT number: NCT07066657
Sponsor: ArriVent BioPharma, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors Colorectal Cancer Gastric Cancer Pancreatic Cancer

Start date: 2025-07-25
Primary completion: 2028-03-01
Enrollment: 572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.